Lymphoedema and cellulitis: Chicken or egg?

British Journal of Dermatology

Volumn 158, Issue 6, 2008, Pages 1175-1176

  Keeley, V L ^a  

^a DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXC2; VASCULOTROPIN RECEPTOR 3;

CELLULITIS; DISEASE CLASSIFICATION; EDITORIAL; GENE MUTATION; HUMAN; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOGRAPHY; LYMPHOSCINTIGRAPHY; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT;

CELLULITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHEDEMA; PHENOTYPE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 43749120898     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08590.x     Document Type: Editorial

References (16)

1. Consensus Document of the International Society of Lymphology Executive Committee. The diagnosis and treatment of peripheral lymphoedema. Lymphology 2003 36 : 84 91.
2. Williams AF, Franks PJ, Moffatt CJ. Lymphoedema: estimating the size of the problem. Palliat Med 2005 19 : 300 13.
3. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985 76 : 206 18.
4. Browse N. Lymphangiomata, lymph cysts and fistulae, lymphangiomatosis and lymphangiosarcomas. In : Diseases of the Lymphatics (Browse N, Burnard KG, Mortimer PS, eds). London : Arnold, 2003 304 24.
5. Karkkainen MJ, Ferrell RE, Lawrence EC et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000 25 : 153 9.
6. Brice G, Child AH, Evans A et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet 2005 42 : 98 102.
7. Bollinger A, Isenring G, Franzeck UK, Brunner U. Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). Lymphology 1983 16 : 27 30.
8. Fang J, Dagenais SL, Erickson RP et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000 67 : 1382 8.
9. Brice G, Mansour S, Bell R et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002 39 : 478 83.
10. Rosbotham JL, Brice GW, Child AH et al. Distichiasis-lymphoedema: clinical features, venous function and lymphoscintigraphy. Br J Dermatol 2000 142 : 148 52.
11. Dupuy A, Benchikhi H, Roujeau J-C et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999 318 : 1591 4.
12. Mallon E, Powell S, Mortimer P, Ryan TJ. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997 137 : 928 33.
13. de Godoy JMP, de Godoy MF, Velente A et al. Lymphoscintigraphic evaluation in patients after erysipelas. Lymphology 2000 33 : 177 80.
14. Stöberl C, Partsch H. Erysipel und Lymphödem - Ei oder Henne? Z Hautkr 1987 62 : 56 62.
15. Damstra RJ, van Steensel MAM, Boomsma JHB et al. Erysipelas as a sign of subclinical primary lymphoedema: a prospective quantitative scintigraphic study of 40 patients with unilateral erysipelas of the leg. Br J Dermatol 2008 158 : 1210 15.
16. Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol 2008 158 : 1350 3.